- Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease
- Personalized Approach May Improve Hypertrophic Cardiomyopathy Diagnosis
- Safeguarding Biomedical Research Investments
- Letter by Pasupathy et al Regarding Article, “Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial”
- Computational Modeling Predicts Benefits of Proefferocytic Therapy in Human Atherosclerosis
- Letter by Zhao Regarding Article, “Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial”
- The Elusiveness of “Rest”: The Challenges of Assessing Resting Coronary Physiology
- A Pause, A Block, A Path Restored: The Heart’s Hidden Choreography
- Optimizing Sedation Strategies for Catheter Ablation Procedures: Balancing Safety, Efficacy, and Practice Variations
- Early Vascular Aging Determined by 3-Dimensional Aortic Geometry: Genetic Determinants and Clinical Consequences
- Neurodevelopmental Outcomes in Early Adolescence: The Pediatric Heart Network Single Ventricle Reconstruction Trial
- PIEZO1 Overexpression in Hereditary Hemorrhagic Telangiectasia Arteriovenous Malformations
- Unique Role of Intracellular Perinuclear β1-Adrenergic Receptors in Defining Signaling Compartmentation and Pathological Cardiac Remodeling
- DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases
- Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study
